Neuroprotective effects of edaravone: Recent insights

Journal of the Neurological Sciences

Volumn 331, Issue 1-2, 2013, Pages 177-

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; NORPHENAZONE;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; HEARING IMPAIRMENT; HUMAN; LETTER; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIPLE SCLEROSIS; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE;

EID: 84882456473     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.05.002     Document Type: Letter

References (7)

1. Kimura K, Aoki J, Sakamoto Y, Kobayashi K, Sakai K, Inoue T, et al. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients-a preliminary study. J Neurol Sci 2012;313:132-6.
2. Yuan WJ, Yasuhara T, Shingo T. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.BMC Neurosci 2008;9(75) [2202-9-75].
3. Yan Y, Gong K, Ma T. Protective effect of edaravone against Alzheimer's disease-relevant insults in neuroblastoma N2a cells. Neurosci Lett 2012;531: 160-5.
4. Ito H, Wate R, Zhang J. Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice. Exp Neurol 2008;213:448-55.
5. Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (phase II study). Amyotroph Lateral Scler 2006;7:241-5.
6. Moriya M, Nakatsuji Y, Miyamoto K. Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis. Neurosci Lett 2008;440:323-6.
7. Tanaka K, Takemoto T, Sugahara K. Post-exposure administration of edaravone attenuates noise-induced hearing loss. Eur J Pharmacol 2005;522:116-21.